Patrick, SW, et al. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. Journal of Perinatology 2015; 35(8): 650–655.
Patrick, SW, et al. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000–2009. JAMA 2012; 307(18): 1934–1940.
Corr, TE, Hollenbeak, CS. The economic burden of neonatal abstinence syndrome in the United States. Addiction 2017; 112(9): 1590–1599.
Hudak, ML, Tan, RC. Committee on Drugs, Committee On Fetus and Newborn, American Academy of Pediatrics. Neonatal drug withdrawal. Pediatrics 2012; 129(2): 540–560.
Ornoy, A, et al. Developmental outcome of school-age children born to mothers with heroin dependency: importance of environmental factors. Developmental Medicine and Child Neurology 2001; 43(10): 668–675.
Villapiano, NL, et al. Rural and urban differences in neonatal abstinence syndrome and maternal opioid use, 2004 to 2013. JAMA Pediatrics 2017; 171(2): 194–196.
Arlettaz, R, et al. Methadone maintenance program in pregnancy in a Swiss perinatal center (II): neonatal outcome and social resources. Acta Obstetricia et Gynecologica Scandinavica 2005; 84(2): 145–150.
Hunt, RW, et al. Adverse neurodevelopmental outcome of infants exposed to opiate in-utero. Early Human Development 2008; 84(1): 29–35.
Kayemba-Kay’s, S, Laclyde, JP. Buprenorphine withdrawal syndrome in newborns: a report of 13 cases. Addiction 2003; 98(11): 1599–1604.
O’Donnell, M, et al
. Increasing prevalence of neonatal withdrawal syndrome: population study of maternal factors and child protection involvement. Pediatrics 2009; 123(4): 614–621.
Brown, JD, Goodin, AJ, Talbert, JC. Rural and Appalachian disparities in neonatal abstinence syndrome incidence and access to opioid abuse treatment. The Journal of Rural Health 2017; 34(1): 6–13.
Moher, D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of Internal Medicine 2009; 151(4): 264–269, W264.
Kivisto, K, et al. Dental health of young children prenatally exposed to buprenorphine. A concern of child neglect? European Archives of Paediatric Dentistry 2014; 15(3): 197–202.
Kelly, LE, et al. Oral morphine weaning for neonatal abstinence syndrome at home compared with in-hospital: an observational cohort study. Paediatric Drugs 2015; 17(2): 151–157.
Payot, A, Berner, M. Hospital stay and short-term follow-up of children of drug-abusing mothers born in an urban community hospital--a retrospective review. European Journal of Pediatrics 2000; 159(9): 679–683.
Olson, LM, Tang, SF, Newacheck, PW. Children in the United States with discontinuous health insurance coverage. The New England Journal of Medicine 2005; 353(4): 382–391.
Oei, J, Feller, JM, Lui, K. Coordinated outpatient care of the narcotic-dependent infant. Journal of Paediatrics and Child Health 2001; 37(3): 266–270.
Gill, AC, et al. Strabismus in infants of opiate-dependent mothers. Acta paediatrica 2003; 92(3): 379–385.
Mayer, ML, Slifkin, RT, Skinner, AC. The effects of rural residence and other social vulnerabilities on subjective measures of unmet need. Medical Care Research and Review 2005; 62(5): 617–628.
Fang, SY, et al. Health insurance coverage and healthcare utilization among infants of mothers in the national methadone maintenance treatment program in Taiwan. Drug and Alcohol Dependence 2015; 153: 86–93.
Patrick, SW, et al. Risk of hospital readmission among infants with neonatal abstinence syndrome. Hospital Pediatrics 2015; 5(10): 513–519.
Uebel, H, et al. Reasons for rehospitalization in children who had neonatal abstinence syndrome. Pediatrics 2015; 136(4): e811–e820.
Witt, CE, et al. Neonatal abstinence syndrome and early childhood morbidity and mortality in Washington state: a retrospective cohort study. Journal of Perinatology 2017; 7(10): 1124–1129.
Chau, KT, et al. Outpatient management of neonatal abstinence syndrome: a quality improvement project. Joint Commission Journal on Quality and Patient Safety 2016; 42(11): 506–515.
Lai, A, et al. An outpatient methadone weaning program by a neonatal intensive care unit for neonatal abstinence syndrome. Population Health Management 2017; 20(5): 397–401.
Backes, CH, et al. Neonatal abstinence syndrome: transitioning methadone-treated infants from an inpatient to an outpatient setting. Journal of Perinatology 2012; 32(6): 425–430.
Dickes, L, et al. Potential for Medicaid savings: a state and national comparison of an innovative neonatal abstinence syndrome treatment model. Population Health Management 2017; 20(6): 458–464.
Smirk, CL, et al. Home-based detoxification for neonatal abstinence syndrome reduces length of hospital admission without prolonging treatment. Acta Paediatrica 2014; 103(6): 601–604.
Cummings, JR, et al. The effects of varying periods of uninsurance on children’s access to health care. Pediatrics 2009; 123(3): 411–418.
Weller, WE, Minkovitz, CS, Anderson, GF. Utilization of medical and health-related services among school-age children and adolescents with special health care needs (1994 National Health Interview Survey on Disability [NHIS-D] Baseline Data). Pediatrics 2003; 112(3 Pt 1): 593–603.
Feinberg, E, et al. Family income and the impact of a children’s health insurance program on reported need for health services and unmet health need. Pediatrics 2002; 109(2): E29.
Mayer, ML, et al. Unmet need for routine and specialty care: data from the National Survey of Children With Special Health Care Needs. Pediatrics 2004; 113(2): e109–e115.
Davidoff, A, Kenney, G, Dubay, L. Effects of the State Children’s Health Insurance Program Expansions on children with chronic health conditions. Pediatrics 2005; 116(1): 34–42.
Kaestner, R, Joyce, T, Racine, A. Medicaid eligibility and the incidence of ambulatory care sensitive hospitalizations for children. Social Science & Medicine 2001; 52(2): 305–313.
O’Grady, MJ, Hopewell, J, White, MJ. Management of neonatal abstinence syndrome: a national survey and review of practice. Archives of Disease in Childhood 2009; 94(4): 249–252.